Review Test Submission: Final Exam - Week 11

User +A1

Course DNRS-6630-5/NURS-6630N-5/NURS-6630C-5/NURS-6630F-5/DNRS-

 6630F-5- Approaches to Treatment-2021-Summer-QTR-Term-wks-1-thru-

 11-(05/31/2021-

 08/15/2021)-PT27

Test Final Exam - Week 11

Started 8/12/21 8:32 AM

Submitted 8/12/21 10:06 AM

Due Date 8/16/21 1:59 AM

Status Completed

Attempted Score 92 out of 100 points

Time Elapsed 1 hour, 34 minutes out of 2 hours and 30 minutes

Results Displayed Feedback

Question 1

L. J. is a 55-year-old male who attended a funeral and found himself laughing

during the service, but later that evening he was irritated with himself for what he

had done. His wife said this was abnormal behavior and took him to his doctor to

be evaluated. After L. J.’s MRI was reviewed, he was diagnosed with

frontotemporal dementia. Which medication is recommended to help L. J. with

his emotional outbursts?

A . Memantine

B . Escitalopram

C . Donepezil

D . Risperidone

Your text here

Response Feedback: under Treatment subtitle: “The behavioral features are

sometimes helped by SSRIs, and these are the best-studied treatments for these

disorders.”

Question 2

When can buprenorphine be initiated in a patient who is suffering from an opioid

overdose?

A . As soon as the patient is stabilized

B . It should be administered as soon as you find the patient unconscious

C . Right after naloxone is administered to prevent the patient from going back

into opioid overdose

D . When the patient is experiencing mild-to-moderate symptoms of withdrawal

Response Feedback: “To avoid this problem, the initial buprenorphine dose

should not be administered until the patient demonstrates mild-to-moderate

symptoms of withdrawal.”

Question 3

Of the following neurotransmitters, which one(s) are known to be severely

disrupted in the disease Dementia with Lewy Bodies?

I. Acetylcholine

II. Glutamate

III. Dopamine

IV. GABA

V. Norepinephrine

A . II only

B . III only

C . I and II

D . I and III

Response Feedback: under pathophysiology subtitle: “It is clear that both the

cholinergic and dopaminergic neurotransmitter systems are severely disrupted.”

Question 4

Choose the correct statement regarding medications used for alcoholism

A . Disulfiram: NMDA receptor antagonist & GABAA agonist

B . Naltrexone: µ-opioid receptor antagonist that reduces the

reinforcement/euphoria produced by alcohol

C . Acamprosate: enhances the effect of the inhibitory neurotransmitter gammaaminobutyric acid on the GABA receptors by binding to a site that is distinct from

the GABA binding site in the central nervous system.

D . Lorazepam: inhibits alcohol dehydrogenase, leading to a buildup of

acetaldehyde

Response Feedback: Table 15-3 has the three MOAs listed for the FDA-approved

treatments of alcoholism.

Question 5

Patient is a 75-year-old female with a confirmed diagnosis of Alzheimer’s Disease.

She is currently on Donepezil 10 mg daily. She is accompanied to your clinic today

by her daughter, who informs you that her mother has recently had an increase in

depressive symptoms. She has no history of mood disorders. She has a history of

hypertension and tonic-clonic seizures, but both are controlled. Assuming this

patient will be thoroughly evaluated for the diagnosis of depression, what would

you recommend as initial therapy?

A . Amitriptyline

B . Doxepin

Powered by qwivy(www.qwivy.org)